Skip to content
Screener

QuidelOrtho Corporation QDEL North America — Total revenues

Other segment segments

EMEA
$91.2M+4.5%
JPAC
$74.3M+2.9%
Latin America
$70.2M+16.4%
China
$67.8M-18.7%

Similar metrics at other companies

Veeva Systems logo
VEEVNorth America — Total revenues
$526.17M+14.5%
LanzaTech Global, Inc. logo
LNZANorth America — Total revenues
$2.59M-12.8%
Americold Realty Trust logo
COLDNorth America — Total revenues
$504.35M-1.3%
FTAI Aviation Ltd. logo
FTAINorth America — Total revenues
$510.67M+126%
GATX logo
GATXRail North America — Total revenues
$436.7M+48.9%
Artivion logo
AORTNorth America — Total revenues
$62.33M+8.3%

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$1.11B-30.1%
Enterprise value$4.42B-7.4%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0001906324-26-000033
(In millions)North AmericaEMEAChinaJPACLatin AmericaTotal
Total revenues$327.4$91.2$67.8$74.3$70.2$630.9
Less (1):
Cost of sales, excluding amortization of intangibles116.744.328.843.338.3271.4
Selling, marketing and administrative40.723.99.512.313.299.6
Research and development0.40.10.60.30.62.0
Other expense, net0.8(1.4)0.1(1.6)(2.1)
Total segment Adjusted EBITDA$169.6$22.1$30.3$18.3$19.7260.0
Reconciliation of segment Adjusted EBITDA

Item 1. Financial Statements (unaudited)

FAQ

What is QuidelOrtho Corporation's north america — total revenues?
QuidelOrtho Corporation (QDEL) reported north america — total revenues of $327.4M in Q2 2026.
How has QuidelOrtho Corporation's north america — total revenues changed year-over-year?
QuidelOrtho Corporation's north america — total revenues increased by 5.4% year-over-year, from $310.7M to $327.4M.
What is the long-term trend for QuidelOrtho Corporation's north america — total revenues?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's north america — total revenues has grown at a -0.2% compound annual growth rate (CAGR), from $1.5B to $1.49B.
What does north america — total revenues mean?
Represents the total gross income generated from the sale of diagnostic testing solutions and services within the North American market. This metric serves as a primary indicator of the company's market penetration and demand for its immunoassay and molecular testing products in the region.

Ask your AI about QuidelOrtho Corporation's north america — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude